Media ReleasesImugene Limited

View All Imugene Limited News


Imugene Announces Appointment of Distinguished Scientist, Dr Michael Caligiuri of City of Hope to Scientific Advisory Board

- President of City of Hope National Medical Center and holds the Deana and Steve Campbell Physician-in-Chief.

- Elected President of the American Association for Cancer Research (AACR) in 2017, the world’s largest cancer research organization.

Sydney, Australia, 07 January 2019: Imugene Limited (ASX:IMU) a clinical stage immuno-oncology company today announced the appointment of Professor Michael Caligiuri, President of the City of Hope National Medical Center in Los Angeles, to its Scientific Advisory Board (SAB).

Dr. Caligiuri is a world renowned cancer researcher and physician whose clinical work has focused on leukemia and lymphoma.


For further information please download PDF attached:
Download this document